#200: Insulin and QWINT-1 Trial in T2DM: Beyond Journal Club Segment with NEJM Group
About this episode
This episode reviews the T2D medication toolkit and discusses new evidence on once-weekly insulin to help individualize therapy while reducing treatment burden.
From metformin to basal insulin to overlooked older medications, this episode reviews the T2D medication toolkit clinicians use every day. We then dive into new evidence on once-weekly insulin to help you individualize therapy while reducing treatment burden. 🔹 Sponsor : Pain Management and Opioids Adaptive Learning Free Online Course by NEJM Group: https://cme-info.nejm.org/core-im/ 🔹 Transcript and Shownotes : 00.58 | Insulin Hx & Types 06:00 | Indications for Insulin and the Burden on Patients 08:26 | What is the QWINT-1 Trial? 16:18 | Discussion Tags: CoreIM, Internal Medicine, Evidence-Based Medicine, Insulin Resistance, Clinical Reasoning, Hospital Medicine, Medical Education, Endocrine, Endocrinology Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840 Our Sponsors: * Check out Branch Basics and use my code branchbasics.com/COREIM for a great deal: https://branchbasics.com * Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com * Check out Quince for high-quality clothes with affordable pricing and use code quince.com/coreim Advertising Inquiries: https://redcircle.com/brands Privacy &…
Sponsors
NEJM Group, Pattern Life, Quince, FIGS
More episodes of Core IM | Internal Medicine Podcast
- #205 Nutrition Studies, Coffee and the CRAVE Trial: Beyond Journal Club with the NEJM Group
- #204 Diabetic Foot Infections & Osteomyelitis: 5 Pearls Segment
- #203 POCUS for AKI & Dialysis | Real Cases That Changed Management
- #202 Dementia Part 2: Gray Matters Segment
- #201: Dementia Part 1: Gray Matters Segment
- #199 Privacy & Confidentiality: At the Bedside Segment
Explore listener stats, chart rankings, contacts and more on the Core IM | Internal Medicine Podcast podcast page.